{"id":"https://openalex.org/W586105329","doi":null,"title":"Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice.","display_name":"Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice.","publication_year":1996,"publication_date":"1996-06-01","ids":{"openalex":"https://openalex.org/W586105329","mag":"586105329","pmid":"https://pubmed.ncbi.nlm.nih.gov/8905797"},"language":"en","primary_location":{"id":"pmid:8905797","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8905797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M Ukai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96636082","display_name":"Meijo University","ror":"https://ror.org/04h42fc75","country_code":"JP","type":"education","lineage":["https://openalex.org/I96636082"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M Ukai","raw_affiliation_strings":["Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Japan","institution_ids":["https://openalex.org/I96636082"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050472588","display_name":"Norihiro Shinkai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Shinkai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089387849","display_name":"Tsutomu Kameyama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Kameyama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2502,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.42165553,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"16","issue":"3","first_page":"97","last_page":"101"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10448","display_name":"Memory and Neural Mechanisms","score":0.017999999225139618,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.010900000110268593,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neurokinin-a","display_name":"neurokinin A","score":0.996999979019165},{"id":"https://openalex.org/keywords/senktide","display_name":"senktide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/scopolamine","display_name":"scopolamine","score":0.8709999918937683},{"id":"https://openalex.org/keywords/neurokinin-2-receptor","display_name":"neurokinin-2 receptor","score":0.7940000295639038},{"id":"https://openalex.org/keywords/neurokinin-3-receptor","display_name":"neurokinin-3 receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tachykinins","display_name":"tachykinins","score":0.8539999723434448},{"id":"https://openalex.org/keywords/spatial-working-memory","display_name":"spatial working memory","score":0.8009999990463257},{"id":"https://openalex.org/keywords/spontaneous-alternation","display_name":"spontaneous alternation","score":0.968999981880188},{"id":"https://openalex.org/keywords/amnesia","display_name":"amnesia","score":0.6520000100135803},{"id":"https://openalex.org/keywords/y-maze-test","display_name":"Y-maze","score":0.7200000286102295},{"id":"https://openalex.org/keywords/receptor-antagonists","display_name":"receptor antagonists","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7218264937400818},{"id":"https://openalex.org/C2777056410","wikidata":"https://www.wikidata.org/wiki/Q408566","display_name":"Neurokinin A","level":5,"score":0.7066562175750732},{"id":"https://openalex.org/C2775847253","wikidata":"https://www.wikidata.org/wiki/Q7579050","display_name":"Spontaneous alternation","level":3,"score":0.6914452314376831},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6746304035186768},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6639639139175415},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6537773609161377},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48946964740753174},{"id":"https://openalex.org/C51296783","wikidata":"https://www.wikidata.org/wiki/Q1645498","display_name":"Microgram","level":3,"score":0.4837336838245392},{"id":"https://openalex.org/C2781359426","wikidata":"https://www.wikidata.org/wiki/Q412604","display_name":"Neurokinin B","level":5,"score":0.47786158323287964},{"id":"https://openalex.org/C202871150","wikidata":"https://www.wikidata.org/wiki/Q12744608","display_name":"NK1 receptor antagonist","level":5,"score":0.4512823522090912},{"id":"https://openalex.org/C2779779143","wikidata":"https://www.wikidata.org/wiki/Q3493547","display_name":"Desensitization (medicine)","level":3,"score":0.42867010831832886},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4241431653499603},{"id":"https://openalex.org/C2776533618","wikidata":"https://www.wikidata.org/wiki/Q411041","display_name":"Substance P","level":4,"score":0.4018251299858093},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.29460012912750244},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27642056345939636},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18307644128799438},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.14124557375907898},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1060006320476532},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0821649432182312}],"mesh":[{"descriptor_ui":"D000647","descriptor_name":"Amnesia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D000647","descriptor_name":"Amnesia","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012601","descriptor_name":"Scopolamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013373","descriptor_name":"Substance P","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013373","descriptor_name":"Substance P","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015288","descriptor_name":"Neurokinin A","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018041","descriptor_name":"Receptors, Neurokinin-2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018041","descriptor_name":"Receptors, Neurokinin-2","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018042","descriptor_name":"Receptors, Neurokinin-3","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018042","descriptor_name":"Receptors, Neurokinin-3","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018782","descriptor_name":"Maze Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8905797","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8905797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology","raw_type":"Journal Article"},{"id":"mag:586105329","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8905797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2030799952","https://openalex.org/W1975028281","https://openalex.org/W2030433029","https://openalex.org/W2018355687","https://openalex.org/W2091855875","https://openalex.org/W1969623416","https://openalex.org/W1992204270","https://openalex.org/W2063431942","https://openalex.org/W2942823276","https://openalex.org/W2011841968"],"abstract_inverted_index":{"The":[0],"effects":[1,113,144,196],"of":[2,5,96,114,123,145,172,183],"intracerebroventricular":[3],"injections":[4],"the":[6,14,91,102,112,120,134,142,155,169,181],"neurokinin-2":[7],"(NK-2)":[8],"receptor":[9,17,136,157],"agonist":[10,18],"neurokinin":[11,78,115,166],"A":[12,58,79,116,167],"and":[13,81,84,87],"neurokinin-3":[15],"(NK-3)":[16],"senktide":[19,62,85,146,188],"on":[20,27,38,119,197],"scopolamine":[21,92,103],"(sc)-induced":[22],"amnesia":[23],"were":[24,127,149],"investigated":[25],"based":[26,37],"spontaneous":[28,70,97,124,173],"alternation":[29,34,71,98,125,174],"performance":[30,35,72,99,126,175],"in":[31,54,107],"mice.":[32],"Spontaneous":[33],"is":[36],"spatial":[39],"working":[40,178],"memory":[41,179],"which":[42],"produces":[43],"a":[44,49,55],"natural":[45],"tendency":[46],"to":[47],"explore":[48],"less":[50],"recently":[51],"visited":[52],"arm":[53,75,109],"Y-maze.":[56],"Neurokinin":[57],"(0.1-3":[59],"micrograms)":[60],"or":[61,73],"(0.0003-0.03":[63],"microgram)":[64,83,89,118,148],"alone":[65],"did":[66],"not":[67,150],"influence":[68],"either":[69],"total":[74,108],"entries.":[76,110],"However,":[77],"(0.3":[80,117],"1":[82],"(0.003":[86,147],"0.03":[88],"inhibited":[90],"(1":[93,104,140],"mg/kg)-induced":[94,105],"impairment":[95,122,171],"without":[100],"affecting":[101],"increase":[106],"Although":[111],"scopolamine-induced":[121,170],"almost":[128],"completely":[129],"antagonized":[130],"by":[131,152],"pretreatment":[132,153],"with":[133,154,177],"NK-2":[135,185],"antagonist":[137,158],"cyclo":[138],"(Gln-Trp-Phe-Gly-Leu-Met)":[139],"microgram),":[141],"inhibitory":[143],"influenced":[151],"NK-3":[156,198],"[Trp7,":[159],"beta-Ala8]neurokinin":[160],"A-(4-10).":[161],"These":[162],"findings":[163],"suggest":[164],"that":[165],"inhibits":[168],"associated":[176],"through":[180],"mediation":[182],"tachykinin":[184],"receptors,":[186],"while":[187],"has":[189],"some":[190],"pharmacological":[191],"action":[192],"other":[193],"than":[194],"its":[195],"receptors.":[199]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}